Parabilis Medicines, Inc.
Prices may be delayed up to 15 min. Not investment advice. News volume: articles in the 4Search index each day.
Key statistics
Against its peers
Compare in full ›| PBLS | IDYA | GENB | PRTA | RXRX | TLX | |
|---|---|---|---|---|---|---|
| Market cap | 3.58B | 3.48B | 1.78B | 432.77M | 2.15B | 3.84B |
| P/E (TTM) | — | — | — | — | — | 112.9 |
| Forward P/E | -13.2 | -9.0 | -6.1 | -5.5 | -4.4 | -420.0 |
| Price/book | 3.4 | 2.9 | 3.9 | 1.5 | 2.3 | 7.9 |
| Dividend yield | — | — | — | — | — | — |
| 1-year change | −13.04% | +34.89% | +13.36% | −14.59% | −21.16% | +17.51% |
| Today | +5.35% | −0.14% | −3.49% | −4.64% | −8.03% | +0.71% |
The closest companies by business and industry (Biotechnology). Prices may be delayed up to 15 min.
Latest news
All PBLS news ›Parabilis Medicines (NASDAQ:PBLS) Stock Price Down 7.6% – What’s Next?
Posted by Michael Walen on Oct 8th, 2026 Parabilis Medicines, Inc. (NASDAQ:PBLS – Get Free Report)’s share price traded down 7.6% during mid-day trading on Thursday. The company traded as low as $26.40 and last traded at $26.62. 145,388…
Parakeet Health Secures $10M Series A
SaasRise Parakeet Health Raises $10M Series A Round Parakeet Health announced a $10 million Series A round on Oct. 1, 2026, led by Canvas Ventures with participation from Blank Space Ventures, StoryHouse Ventures and HMC INQ, bringing its…
From articles in the 4Search news index.
In the news
Mentioned with
People in the coverage
Most coverage from
-
saasrise.com1
-
themarketsdaily.com1
-
ts2.tech1
Finance and business coverage in the 4Search news index: articles that name it in the headline, or in the text beside its ticker. Sentiment is the index's own reading of the latest 3 articles, not a forecast.